STAR Cape+BKM120 MBC with Brain Met

Clinical Trial Details

STAR Cape+BKM120

STAR Cape+BKM120 MBC with Brain Met


Request Additional Trial Information
Full Trial Details:

Condition: Breast Cancer
Study Type: Interventional
Phase: Phase II
Study Start Date: 05/01/2014
Study Completion Date: 01/31/2018

This is a study to determine the safety and effectiveness of BKM120 plus capecitabine in breast cancer patients with brain metastases. Both capecitabine and BMK120 have previously shown acivity in patients with breast cancer. Like capecitabine, BMK120 is also effective in crossing the blood brain barrier making it a preferred candidate for its evaluation in patients with metastatic breast cancer(MBC).

NCT Number
Principal Investigator(s)
John Wallmark, MD
US Oncology Research
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Female


  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.